A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.
Progeny of mice treated with the mutagen N-ethyl-N-nitrosourea (ENU) revealed a mouse, designated Longpockets (Lpk), with short humeri, abnormal vertebrae, and disorganized growth plates, features consistent with spondyloepiphyseal dysplasia congenita (SEDC). The Lpk phenotype was inherited as an autosomal dominant trait. Lpk/+ mice were viable and fertile and Lpk/Lpk mice died perinatally. Lpk was mapped to chromosome 15 and mutational analysis of likely candidates from the interval revealed a Col2a1 missense Ser1386Pro mutation. Transient transfection of wild-type and Ser1386Pro mutant Col2a1 c-Myc constructs in COS-7 cells and CH8 chondrocytes demonstrated abnormal processing and endoplasmic reticulum retention of the mutant protein. Histology revealed growth plate disorganization in 14-day-old Lpk/+ mice and embryonic cartilage from Lpk/+ and Lpk/Lpk mice had reduced safranin-O and type-II collagen staining in the extracellular matrix. The wild-type and Lpk/+ embryos had vertical columns of proliferating chondrocytes, whereas those in Lpk/Lpk mice were perpendicular to the direction of bone growth. Electron microscopy of cartilage from 18.5 dpc wild-type, Lpk/+, and Lpk/Lpk embryos revealed fewer and less elaborate collagen fibrils in the mutants, with enlarged vacuoles in the endoplasmic reticulum that contained amorphous inclusions. Micro-computed tomography (CT) scans of 12-week-old Lpk/+ mice revealed them to have decreased bone mineral density, and total bone volume, with erosions and osteophytes at the joints. Thus, an ENU mouse model with a Ser1386Pro mutation of the Col2a1 C-propeptide domain that results in abnormal collagen processing and phenotypic features consistent with SEDC and secondary osteoarthritis has been established.
Academic Endocrine Unit, Nuffield Department of Clinical Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Headington, Oxford, United Kingdom.
Christopher T
CT
Esapa
Tertius A
TA
Hough
Sarah
S
Testori
Rosie A
RA
Head
Elizabeth A
EA
Crane
Carol P S
CP
Chan
Holly
H
Evans
J H Duncan
JH
Bassett
Przemko
P
Tylzanowski
Eugene G
EG
McNally
Andrew J
AJ
Carr
Alan
A
Boyde
Peter G T
PG
Howell
Anne
A
Clark
Graham R
GR
Williams
Matthew A
MA
Brown
Peter I
PI
Croucher
M Andrew
MA
Nesbit
Steve D M
SD
Brown
Roger D
RD
Cox
Michael T
MT
Cheeseman
Rajesh V
RV
Thakker
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D019902:Chondrocytes / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D033481:Chromosomes, Mammalian / Q000235:genetics; D024043:Collagen Type II / Q000737:chemistry / Q000235:genetics*; D004195:Disease Models, Animal; D004622:Embryo, Mammalian / Q000002:abnormalities / Q000473:pathology; D056426:Genetic Loci / Q000235:genetics; D006132:Growth Plate / Q000002:abnormalities / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D050505:Mutant Proteins / Q000378:metabolism; D020125:Mutation, Missense / Q000235:genetics*; D009929:Organ Size; D010003:Osteoarthritis / Q000150:complications* / Q000235:genetics*; D010009:Osteochondrodysplasias / Q000150:complications / Q000151:congenital* / Q000235:genetics; D010012:Osteogenesis; D010641:Phenotype; D020161:Physical Chromosome Mapping; D011499:Protein Processing, Post-Translational
C447413:Col2a1 protein, mouse; D024043:Collagen Type II; D050505:Mutant Proteins